
Bastide le Confort (BLC) | Financial Analysis & Statements
Bastide le Confort Médical S.A. | Mid-cap | Healthcare
Bastide le Confort Médical S.A. | Mid-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
647.1M
Total Liabilities
566.3M
Shareholders Equity
80.7M
Debt to Equity
7.02
Cash Flow Metrics
Revenue & Profitability Trend
Bastide le Confort Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 529.8M | 508.0M | 468.3M | 444.1M | 382.7M |
Cost of Goods Sold | 175.3M | 174.3M | 161.5M | 163.8M | 131.1M |
Gross Profit | 354.4M | 333.7M | 306.8M | 280.3M | 251.6M |
Gross Margin % | 66.9% | 65.7% | 65.5% | 63.1% | 65.7% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | 75.0M | 69.8M | 63.9M |
Other Operating Expenses | 89.2M | 86.1M | 80.9M | 74.3M | 67.2M |
Total Operating Expenses | 89.2M | 86.1M | 155.9M | 144.1M | 131.1M |
Operating Income | 44.2M | 42.0M | 38.4M | 37.5M | 33.7M |
Operating Margin % | 8.3% | 8.3% | 8.2% | 8.4% | 8.8% |
Non-Operating Items | |||||
Interest Income | 0 | 0 | 0 | 0 | 2.0K |
Interest Expense | 27.4M | 16.6M | 10.2M | 8.9M | 7.9M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 16.5M | 22.8M | 21.0M | 20.2M | 20.3M |
Income Tax | 7.0M | 6.0M | 5.9M | 5.8M | 7.7M |
Effective Tax Rate % | 42.5% | 26.2% | 28.2% | 28.9% | 37.8% |
Net Income | 1.2M | 12.8M | 14.3M | 14.3M | 12.6M |
Net Margin % | 0.2% | 2.5% | 3.1% | 3.2% | 3.3% |
Key Metrics | |||||
EBITDA | 112.5M | 103.5M | 96.5M | 89.1M | 80.3M |
EPS (Basic) | €-0.12 | €1.62 | €1.86 | €1.83 | €1.58 |
EPS (Diluted) | €-0.12 | €1.52 | €1.86 | €1.83 | €1.58 |
Basic Shares Outstanding | 7460450 | 7457499 | 7350928 | 7348419 | 7346611 |
Diluted Shares Outstanding | 7460450 | 7457499 | 7350928 | 7348419 | 7346611 |
Income Statement Trend
Bastide le Confort Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 23.6M | 36.7M | 22.1M | 33.7M | 35.4M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 78.6M | 69.5M | 68.0M | 54.3M | 49.6M |
Inventory | 43.2M | 48.5M | 48.5M | 42.9M | 54.8M |
Other Current Assets | 6.2M | 2.6M | 3.2M | 2.1M | 2.2M |
Total Current Assets | 208.9M | 196.4M | 186.6M | 164.1M | 171.9M |
Non-Current Assets | |||||
Property, Plant & Equipment | 171.4M | 160.9M | 149.9M | 142.0M | 101.8M |
Goodwill | 426.1M | 459.5M | 443.7M | 375.4M | 308.3M |
Intangible Assets | 8.8M | 8.2M | 8.5M | 7.1M | 7.6M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | -1.0K | -1.0K | -3.0K | -1.0K | - |
Total Non-Current Assets | 438.1M | 460.7M | 445.9M | 405.0M | 334.1M |
Total Assets | 647.1M | 657.1M | 632.6M | 569.1M | 506.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 77.0M | 73.1M | 63.8M | 65.0M | 58.3M |
Short-term Debt | 65.9M | 92.3M | 55.9M | 32.3M | 28.3M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 65.4M | 55.4M | 53.7M | 50.2M | 55.5M |
Total Current Liabilities | 216.2M | 225.0M | 175.0M | 147.9M | 142.9M |
Non-Current Liabilities | |||||
Long-term Debt | 342.7M | 335.1M | 363.3M | 325.3M | 278.0M |
Deferred Tax Liabilities | 1.9M | 4.3M | 2.9M | 2.1M | 1.6M |
Other Non-Current Liabilities | 4.1M | 2.7M | 1.3M | 7.8M | 3.3M |
Total Non-Current Liabilities | 350.1M | 344.0M | 370.9M | 336.1M | 283.5M |
Total Liabilities | 566.3M | 569.0M | 545.9M | 484.1M | 426.4M |
Equity | |||||
Common Stock | 3.4M | 3.4M | 3.3M | 3.3M | 3.3M |
Retained Earnings | 66.9M | 74.8M | 71.8M | 68.5M | 62.9M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 80.7M | 88.1M | 86.7M | 85.1M | 79.6M |
Key Metrics | |||||
Total Debt | 408.6M | 427.4M | 419.2M | 357.6M | 306.3M |
Working Capital | -7.3M | -28.6M | 11.6M | 16.2M | 29.0M |
Balance Sheet Composition
Bastide le Confort Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 1.2M | 12.7M | 14.3M | 14.3M | 12.6M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 0 | 850.0K | 339.0K | 383.0K | 264.0K |
Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
Operating Cash Flow | 34.4M | 31.1M | 25.6M | 26.5M | 20.2M |
Investing Activities | |||||
Capital Expenditures | -51.3M | -52.8M | -50.6M | -45.9M | -39.0M |
Acquisitions | 9.7M | -22.0M | -54.4M | -27.0M | -12.5M |
Investment Purchases | -1.5M | -1.2M | 0 | -416.0K | - |
Investment Sales | 0 | 134.0K | 517.0K | 11.0K | 290.0K |
Investing Cash Flow | -42.8M | -75.9M | -104.5M | -73.2M | -51.1M |
Financing Activities | |||||
Share Repurchases | - | - | -240.0K | -747.0K | 0 |
Dividends Paid | -1.6M | -613.0K | -2.4M | -2.1M | -69.0K |
Debt Issuance | 56.9M | 37.0M | 256.3M | 43.0M | 47.9M |
Debt Repayment | -70.1M | -15.2M | -198.8M | -14.7M | -6.8M |
Financing Cash Flow | -15.0M | 21.7M | 54.9M | 25.4M | 41.2M |
Free Cash Flow | 37.3M | 52.0M | 3.6M | 27.8M | 7.5M |
Net Change in Cash | -23.4M | -23.1M | -24.1M | -21.3M | 10.2M |
Cash Flow Trend
Bastide le Confort Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
24.48
Forward P/E
9.37
Price to Book
2.77
Price to Sales
0.38
PEG Ratio
9.37
Profitability Ratios
Profit Margin
0.32%
Operating Margin
9.53%
Return on Equity
10.46%
Return on Assets
4.53%
Financial Health
Current Ratio
1.19
Debt to Equity
541.81
Beta
0.87
Per Share Data
EPS (TTM)
€1.16
Book Value per Share
€10.26
Revenue per Share
€72.38
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
blc | 207.6M | 24.48 | 2.77 | 10.46% | 0.32% | 541.81 |
Laboratoires | 12.1M | 28.20 | 0.73 | -31.26% | -16.78% | 48.76 |
Metrics In Balance | 790.3K | - | 0.01 | -0.45% | -17,317.00% | - |
EssilorLuxottica | 127.0B | 52.88 | 3.31 | 6.44% | 8.74% | 36.58 |
Sartorius Stedim | 17.6B | 76.84 | 4.40 | 5.69% | 7.78% | 73.51 |
bioMérieux S.A | 15.0B | 35.00 | 3.57 | 10.68% | 10.86% | 11.65 |
Financial data is updated regularly. All figures are in the company's reporting currency.